CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - UNAUDITED - USD ($) $ in Thousands	Total	Common Class A	Common Class B	Common Stock	Common Stock Common Class A	Common Stock Common Class B	Preferred Stock	Paid-in Capital	Retained Earnings/(Accumulated Deficit)	Accumulated Other Comprehensive Loss	Noncontrolling interest
Balance at beginning of period (in shares) at Dec. 31, 2020				15,200,000
Balance at beginning of period (in shares) at Dec. 31, 2020							0
Balance at beginning of period at Dec. 31, 2020	$ 212,838			$ 152			$ 0	$ 203,463	$ 9,354	$ (131)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	(20,021)								(13,572)		(6,449)
Issuance of preferred stock (in shares)							225,490,000
Issuance of preferred stock	2						$ 2
Issuance of Noncontrolling interest	179,552							(50,068)			229,620
Common stock issued related to share-based compensation and other, net (in shares)				110,000
Common stock issued related to share-based compensation and other, net	1,772			$ 1				1,769		1	1
Balance at end of period (in shares) at Mar. 31, 2021							225,490,000
Balance at end of period (in shares) at Mar. 31, 2021				15,310,000
Balance at end of period at Mar. 31, 2021	374,143			$ 153			$ 2	155,164	(4,218)	(130)	223,172
Balance at beginning of period (in shares) at Dec. 31, 2020				15,200,000
Balance at beginning of period (in shares) at Dec. 31, 2020							0
Balance at beginning of period at Dec. 31, 2020	212,838			$ 152			$ 0	203,463	9,354	(131)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	30,638
Balance at end of period (in shares) at Sep. 30, 2021							225,490,000
Balance at end of period (in shares) at Sep. 30, 2021				15,331,000
Balance at end of period at Sep. 30, 2021	426,590			$ 153			$ 2	156,950	16,214	(130)	253,401
Balance at beginning of period (in shares) at Mar. 31, 2021				15,310,000
Balance at beginning of period (in shares) at Mar. 31, 2021							225,490,000
Balance at beginning of period at Mar. 31, 2021	374,143			$ 153			$ 2	155,164	(4,218)	(130)	223,172
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,596								3,045		4,551
Common stock issued related to share-based compensation and other, net (in shares)				2,000
Common stock issued related to share-based compensation and other, net	924							922		1	1
Balance at end of period (in shares) at Jun. 30, 2021							225,490,000
Balance at end of period (in shares) at Jun. 30, 2021				15,312,000
Balance at end of period at Jun. 30, 2021	382,663			$ 153			$ 2	156,086	(1,173)	(129)	227,724
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	43,063								17,387		25,676
Common stock issued related to share-based compensation and other, net (in shares)				19,000
Common stock issued related to share-based compensation and other, net	864							864		(1)	1
Balance at end of period (in shares) at Sep. 30, 2021							225,490,000
Balance at end of period (in shares) at Sep. 30, 2021				15,331,000
Balance at end of period at Sep. 30, 2021	426,590			$ 153			$ 2	156,950	16,214	(130)	253,401
Balance at beginning of period (in shares) at Dec. 31, 2021		21,090,259	22,548,998		21,090,000	22,549,000
Balance at beginning of period at Dec. 31, 2021	669,508				$ 729	$ 2		273,329	49,583	(111)	345,976
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	(20,661)								(9,985)		(10,676)
Common stock issued related to share-based compensation and other, net (in shares)					56,000
Common stock issued related to share-based compensation and other, net	478							478
Balance at end of period (in shares) at Mar. 31, 2022					21,146,000	22,549,000
Balance at end of period at Mar. 31, 2022	649,325				$ 729	$ 2		273,807	39,598	(111)	335,300
Balance at beginning of period (in shares) at Dec. 31, 2021		21,090,259	22,548,998		21,090,000	22,549,000
Balance at beginning of period at Dec. 31, 2021	669,508				$ 729	$ 2		273,329	49,583	(111)	345,976
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 354,964
Balance at end of period (in shares) at Sep. 30, 2022	0
Balance at end of period (in shares) at Sep. 30, 2022		19,422,156	22,548,998		19,422,000	22,549,000
Balance at end of period at Sep. 30, 2022	$ 964,532				$ 194	$ 2		230,777	215,475	(111)	518,195
Balance at beginning of period (in shares) at Mar. 31, 2022					21,146,000	22,549,000
Balance at beginning of period at Mar. 31, 2022	649,325				$ 729	$ 2		273,807	39,598	(111)	335,300
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	148,040								71,184		76,856
Repurchase of Class A Common Stock (in shares)					(681,000)
Repurchase of Class A Common Stock	(25,059)				$ (7)			(25,052)
Change in ownership, net	0							6,498			(6,498)
Common stock issued related to share-based compensation and other, net (in shares)					18,000
Common stock issued related to share-based compensation and other, net	1,845				$ (517)			2,362
Balance at end of period (in shares) at Jun. 30, 2022					20,483,000	22,549,000
Balance at end of period at Jun. 30, 2022	774,151				$ 205	$ 2		257,615	110,782	(111)	405,658
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	227,585								106,236		121,349
Repurchase of Class A Common Stock (in shares)					(1,075,000)
Repurchase of Class A Common Stock	(35,022)				$ (11)			(35,011)
Change in ownership, net	0							7,121			(7,121)
Distributions to Noncontrolling interest	(1,691)										(1,691)
Dividends declared ($0.075 per share of Class A common stock)	(1,543)	$ (3,200)							(1,543)
Common stock issued related to share-based compensation and other, net (in shares)					14,000
Common stock issued related to share-based compensation and other, net	$ 1,052							1,052
Balance at end of period (in shares) at Sep. 30, 2022	0
Balance at end of period (in shares) at Sep. 30, 2022		19,422,156	22,548,998		19,422,000	22,549,000
Balance at end of period at Sep. 30, 2022	$ 964,532				$ 194	$ 2		$ 230,777	$ 215,475	$ (111)	$ 518,195